BioSpace News Archive

Molecular Templates, Inc. today announced the dosing of the first subject in a Phase 1 study investigating MT-6402 in patients with PD-L1-positive solid tumors.

F-star Therapeutics, Inc. today announced that the company will participate in two virtual investor conference events next week. Details are as follows: Ladenburg Thalmann Healthcare Conference 2021

Global Blood Therapeutics, Inc. announced that on July 1, 2021, the compensation committee of GBT’s board of directors granted 23 new employees options to purchase an aggregate of 9,600 shares of the company’s common stock with a per share exercise price of $37.34 and restricted stock units for an aggregate of 94,320 shares of the company’s common stock.

Applied Molecular Transport Inc. today announced additional Phase 1b data for oral AMT-101 in ulcerative colitis (UC) patients.

Reneo Pharmaceuticals, Inc. announced today that Jefferies LLC, SVB Leerink LLC and Piper Sandler, as the representatives of the several underwriters of Reneo’s initial public offering, have agreed to waive the lock-up restriction with respect to 111,736 shares of common stock held by Wendy Johnson.

Oryzon Genomics, S.A. presented today preliminary data from the Phase II trial ESCAPE on vafidemstat’s ability to reduce the inflammatory response in COVID-19 patients.

I-Mab today announced the signing of two new collaborations with emerging biotech companies in China to strengthen its next-generation innovation pipeline.

Science Applications International Corp. (NYSE: SAIC ) today announced the appointment of two new senior vice presidents of Human Resources (HR) and a new corporate controller.

bluebird bio, Inc . (Nasdaq: BLUE) today announced that the European Medicines Agency’s (EMA) Pharmacovigilance Risk Assessment Committee (PRAC) has concluded based on the review of all available data that the benefit-risk balance of medicinal products containing ZYNTEGLO™ (betibeglogene autotemcel gene therapy) remains favorable.

electroCore, Inc. today announced that Dan Goldberger, CEO will present a company overview and be available for 1x1 meetings at the following upcoming conference: Ladenburg Thalmann 2021 Virtual Healthcare Conference Presentation Date: July 14, 2021 Presentation Time: 3:30 pm Webcast